國立高雄大學圖資館 |

Language: English

Back

Epigenetics in oncology

Record Type:	Electronic resources : Monograph/item
Title/Author:	Epigenetics in oncologyedited by Jianjun Chen, G. Greg Wang, Jun Lu.
other author:	Chen, Jianjun.
Published:	Cham :Springer International Publishing :2023.
Description:	vi, 393 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	CancerGenetic aspects.
Online resource:	https://doi.org/10.1007/978-3-031-45654-1
ISBN:	9783031456541$q(electronic bk.)

Epigenetics in oncology
Epigenetics in oncology[electronic resource] /edited by Jianjun Chen, G. Greg Wang, Jun Lu. - Cham :Springer International Publishing :2023. - vi, 393 p. :ill., digital ;24 cm. - Cancer treatment and research,v. 1902509-8497 ;. - Cancer treatment and research ;v. 114..

PART I RNA Epigenetics, RNA modifications in cancer metabolism and tumor microenvironment -- RNA modifications in cancer stem cell biology -- Recent advances of RNA m6A modifications in cancer immunoediting and immunotherapy -- Recent advances in RNA m6A modification in solid tumors and tumor immunity -- Recent advances in adenosine-to-inosine RNA editing in cancer -- RNA modification in hematopoietic malignancies -- PART II Histone Epigenetics, The SWI/SNF complex: A frequently-mutated chromatin remodelling complex in cancer -- Histone readers and their roles in cancer -- Polycomb repressive complex 2 in oncology -- Epigenetic (de)regulation in prostate cancer -- PART III DNA Epigenetics, TET methylcytosine dioxygenases in cancer -- Inferring the cancer cellular epigenome heterogeneity via DNA methylation patterns.

This book addresses Epigenetics in Cancer and covers the most recent advances in RNA/histone/DNA epigenetics in Oncology. RNA/histone/DNA epigenetics have been shown to play pivotal roles in cancer initiation, progression, maintenance and drug response/resistance, tumor microenvironment, cancer stem cell self-renewal, cancer metabolism, and tumor immune evasion. In particular, research in RNA cancer epigenetics has made impressive progress in the last few years. Individual chapters in Part I (focusing on RNA epigenetics) are devoted to RNA modifications in Cancer Metabolism and Microenvironment, Cancer Stem Cell Biology, Immune Surveillance, Solid Tumors and Tumor Immunity, and Hematopoietic Malignancies, as well as to RNA editing in Cancer. Chapters in Part II and III of the book focus on histone epigenetics and DNA epigenetics, respectively. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists, graduate students and clinicians alike.

ISBN: 9783031456541$q(electronic bk.)

Standard No.: 10.1007/978-3-031-45654-1doiSubjects--Topical Terms:

189391
Cancer
--Genetic aspects.

LC Class. No.: RC268.4

Dewey Class. No.: 616.994042

Epigenetics in oncology
LDR:02889nmm a2200337 a 4500 001 653478
003 DE-He213
005 20231219152554.0
006 m d
007 cr nn 008maaau
008 240426s2023 sz s 0 eng d
020 $a 9783031456541$q(electronic bk.)
020 $a 9783031456534$q(paper)
024 7 $a 10.1007/978-3-031-45654-1 $2 doi
035 $a 978-3-031-45654-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994042 $2 23
090 $a RC268.4 $b .E64 2023
245 0 0 $a Epigenetics in oncology $h [electronic resource] / $c edited by Jianjun Chen, G. Greg Wang, Jun Lu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a vi, 393 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer treatment and research, $x 2509-8497 ; $v v. 190
505 0 $a PART I RNA Epigenetics, RNA modifications in cancer metabolism and tumor microenvironment -- RNA modifications in cancer stem cell biology -- Recent advances of RNA m6A modifications in cancer immunoediting and immunotherapy -- Recent advances in RNA m6A modification in solid tumors and tumor immunity -- Recent advances in adenosine-to-inosine RNA editing in cancer -- RNA modification in hematopoietic malignancies -- PART II Histone Epigenetics, The SWI/SNF complex: A frequently-mutated chromatin remodelling complex in cancer -- Histone readers and their roles in cancer -- Polycomb repressive complex 2 in oncology -- Epigenetic (de)regulation in prostate cancer -- PART III DNA Epigenetics, TET methylcytosine dioxygenases in cancer -- Inferring the cancer cellular epigenome heterogeneity via DNA methylation patterns.
520 $a This book addresses Epigenetics in Cancer and covers the most recent advances in RNA/histone/DNA epigenetics in Oncology. RNA/histone/DNA epigenetics have been shown to play pivotal roles in cancer initiation, progression, maintenance and drug response/resistance, tumor microenvironment, cancer stem cell self-renewal, cancer metabolism, and tumor immune evasion. In particular, research in RNA cancer epigenetics has made impressive progress in the last few years. Individual chapters in Part I (focusing on RNA epigenetics) are devoted to RNA modifications in Cancer Metabolism and Microenvironment, Cancer Stem Cell Biology, Immune Surveillance, Solid Tumors and Tumor Immunity, and Hematopoietic Malignancies, as well as to RNA editing in Cancer. Chapters in Part II and III of the book focus on histone epigenetics and DNA epigenetics, respectively. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists, graduate students and clinicians alike.
650 0 $a Cancer $x Genetic aspects. $3 189391
650 0 $a Epigenetics. $3 560256
650 1 4 $a Oncology. $3 195181
700 1 $a Chen, Jianjun. $3 964028
700 1 $a Wang, G. Greg. $3 964029
700 1 $a Lu, Jun. $3 964030
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Cancer treatment and research ; $v v. 114. $3 452091
856 4 0 $u https://doi.org/10.1007/978-3-031-45654-1
950 $a Medicine (SpringerNature-11650)